Jagsonpal Pharmaceuticals Share Price
JAGSNPHARM
₹---₹-- (--%) Past Year
₹--₹--
LH
What’s in news?
No data available at the moment
Company overview
About
Market cap
| Open₹-- | Close₹-- |
Circuit range₹-- - ₹-- | Day range₹-- - ₹-- | Year range₹-- - ₹-- |
Volume-- | Avg. traded₹-- | Revenue (12m)₹NaN undefined |
Jagsonpal PharmaceuticalsJagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its formulation products include Divatrone, Maintane 500 injection, Maintane 250 injection, Maintane Tablet, Indocap capsules, Metadec 50 injection, Metadec 25 injection, EndoReg Tablet, LycoRed softgels, LycoRed syrup, Doxypal DR-L Capsule, Yuliprist Tablet, COLLA-2 Tablet, Cystelia M, and DeeReg Tablet, among others. Its OTC products include Ringcuter Cream, Skin Lumia Soap-Antibacterial, and Skin Lumia Soap-Neem Tulsi. Its Naari products include Endoreg, Yuliprist, Verena, Kyrah, Krampoff, Endonorm EV2, Divagest SR 300, Divagest SR 200, Cystelia 35, Fibristone 25, and Cystelia-M. Its other products include Lycored Softgels, Lycored Syrup, JP Tone Syrup, and Doxypal DR-L. The Company’s therapy areas include gynecology, orthopedics, and others.
Read more
Jagsonpal Pharmaceuticals Key indicators
52 week high₹-- | 52 week low₹-- | P/E ratio |
P/B ratio | ROE-- | ROCE-- |
Dividend yield-- | Debt/Equity ratio | EPS |
Learn more
Featured in
Fundamentals
Financial ratios
Operating profit margin-- | Net profit margin-- |
ROE-- | ROA-- |
ROCE-- |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Jagsonpal Pharmaceuticals Share Price history
Day | Open | Close | Day’s change |
---|
Events
No data available at the moment
More
Similar stocks
People also bought
Investment calculators
Upcoming IPOs
No data available at the moment